Functional food regulation
This article was originally published in The Tan Sheet
Executive Summary
FDA should implement GAO's recommendations for regulation of functional foods, including establishing "advisory committee to reevaluate the current labeling approaches for foods with novel ingredients," Center for Science in the Public Interest say in a March 21 citizen petition. Premarket notification of novel functional food ingredients is warranted because FDA "needs to determine whether instructions for use are required and whether the manufacturer needs to specify" how often food should be consumed, CSPI says. GAO report, issued July 2000, also suggested Congress amend the FD&C Act to harmonize dietary supplement, functional food standards (1"The Tan Sheet" July 17, 2000, p. 14)...
You may also be interested in...
Dietary Supplement, Functional Food Regulatory Harmonization Urged By GAO
Congress should amend the FD&C Act to require that functional foods meet the same regulatory standards that dietary supplements meet, the General Accounting Office recommends in a July 11 report.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.